Jack Nathan Medical Corp.

TSXV:JNH Stock Report

Market Cap: CA$1.7m

Jack Nathan Medical Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Glenn Copeland

Chief executive officer

CA$865.5k

Total compensation

CEO salary percentage86.9%
CEO tenure3.3yrs
CEO ownershipn/a
Management average tenure3.3yrs
Board average tenure4.3yrs

Recent management updates

Recent updates

Not Many Are Piling Into Jack Nathan Medical Corp. (CVE:JNH) Stock Yet As It Plummets 44%

Aug 12
Not Many Are Piling Into Jack Nathan Medical Corp. (CVE:JNH) Stock Yet As It Plummets 44%

Jack Nathan Medical Corp. (CVE:JNH) Might Not Be As Mispriced As It Looks After Plunging 33%

Jun 28
Jack Nathan Medical Corp. (CVE:JNH) Might Not Be As Mispriced As It Looks After Plunging 33%

Jack Nathan Medical Corp.'s (CVE:JNH) Shares Leap 30% Yet They're Still Not Telling The Full Story

Feb 07
Jack Nathan Medical Corp.'s (CVE:JNH) Shares Leap 30% Yet They're Still Not Telling The Full Story

Fewer Investors Than Expected Jumping On Jack Nathan Medical Corp. (CVE:JNH)

Oct 27
Fewer Investors Than Expected Jumping On Jack Nathan Medical Corp. (CVE:JNH)

Jack Nathan Medical Corp. (CVE:JNH) Insiders Increased Their Holdings

Dec 31
Jack Nathan Medical Corp. (CVE:JNH) Insiders Increased Their Holdings

CEO Compensation Analysis

How has Glenn Copeland's remuneration changed compared to Jack Nathan Medical's earnings?
DateTotal CompensationSalaryCompany Earnings
Jul 31 2024n/an/a

-CA$9m

Apr 30 2024n/an/a

-CA$8m

Jan 31 2024CA$866kCA$752k

-CA$7m

Oct 31 2023n/an/a

-CA$8m

Jul 31 2023n/an/a

-CA$7m

Apr 30 2023n/an/a

-CA$6m

Jan 31 2023CA$831kCA$750k

-CA$7m

Oct 31 2022n/an/a

-CA$6m

Jul 31 2022n/an/a

-CA$7m

Apr 30 2022n/an/a

-CA$8m

Jan 31 2022CA$330kCA$229k

-CA$8m

Compensation vs Market: Glenn's total compensation ($USD602.29K) is above average for companies of similar size in the Canadian market ($USD164.07K).

Compensation vs Earnings: Glenn's compensation has increased whilst the company is unprofitable.

CEO

Glenn Copeland

3.3yrs

Tenure

CA$865,520

Compensation

Dr. Glenn Copeland serves as Chief Medical Officer at Jack Nathan Medical Corp. since December 2020 and serves as its Chief Executive Officer since September 7, 2021 and serves as its President and also se...

Leadership Team

NamePositionTenureCompensationOwnership
Glenn Copeland
CEO, President3.3yrsCA$865.52kno data
Michael Marchelletta
Co-Founder & Executive Vice-Chairman4.3yrsCA$52.50k24.36%
CA$ 424.4k
Marcy Herriman
Chief Operating Officer3.1yrsCA$293.62kno data
Serge Cinelli
Chief Technology Officer4.2yrsno datano data

3.3yrs

Average Tenure

Experienced Management: JNH's management team is considered experienced (3.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Glenn Copeland
CEO, President2yrsCA$865.52kno data
Michael Marchelletta
Co-Founder & Executive Vice-Chairman4.3yrsCA$52.50k24.36%
CA$ 424.4k
Blake Lyon
Independent Director4.3yrsCA$46.90kno data
Anthony DeCristofaro
Independent Director4.3yrsCA$49.60kno data

4.3yrs

Average Tenure

Experienced Board: JNH's board of directors are considered experienced (4.3 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 05:34
End of Day Share Price 2024/12/20 00:00
Earnings2024/07/31
Annual Earnings2024/01/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Jack Nathan Medical Corp. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution